✦ LIBER ✦

Molecular evidence for increased antitumor activity of gemcitabine in combination with a cyclin-dependent kinase inhibitor, P276-00 in pancreatic cancers

✍ Scribed by Maggie J Rathos, Kavita Joshi, Harshal Khanwalkar, Sonal M Manohar, Kalpana S Joshi

Book ID: 119905231
Publisher: BioMed Central
Year: 2012
Tongue: English
Weight: 719 KB
Volume: 10
Category: Article
ISSN: 1479-5876
DOI: 10.1186/1479-5876-10-161

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

BAY 1000394, a Novel Cyclin-Dependent Ki

BAY 1000394, a Novel Cyclin-Dependent Kinase Inhibitor, with Potent Antitumor Activity in Mono- and in Combination Treatment upon Oral Application

✍ Siemeister, G.; Lucking, U.; Wengner, A. M.; Lienau, P.; Steinke, W.; Schatz, C. 📂 Article 📅 2012 🏛 American Association for Cancer Research 🌐 English ⚖ 787 KB